The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Purchase of new London Hotel

2 Jun 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Purchase of new London Hotel 02-Jun-2023 / 07:00 GMT/BST


 

 

Dalata Hotel Group announces purchase of Apex Hotel London Wall for

£53.4 million

Hotel will be the Group’s 5th Hotel in London

 

 

ISE: DHG  LSE: DAL

 

Dublin, London, 2nd June 2023| Dalata Hotel Group plc (“Dalata” or “the Company”) is pleased to announce that it has exchanged contracts to acquire the long leasehold interest of the Apex Hotel London Wall (“the Hotel” or “the Property”), for consideration and a gross asset value of £53.4 million (€62.2 million) from Apex Hotels Limited (“Apex”), subject to standard contractual conditions and approvals.

Apex owns the long leasehold interest, with 107 years remaining on the lease, of the Hotel situated at 7-9 Copthall Ave, London EC2R 7NJ, in the heart of the City of London. The consideration will be payable from Dalata’s existing facilities and the transaction is expected to complete in early July 2023.

The existing Property is an Upper Upscale Hotel, with full four-star facilities consisting of 89 bedrooms and suites, a gym, ground floor lobby and a contemporary restaurant and bar. The Hotel is conveniently located less than 10 minutes’ walk from Moorgate, Bank and Liverpool Street Stations which have extensive National Rail, London Underground and bus services, providing excellent connectivity across London. The Property, with expected EBITDAR of approximately £4.5 million in 2024, will require minimal initial investment and, on completion of the transaction, Dalata will rebrand the Hotel as Clayton Hotel London Wall.

The acquisition of this going concern in a prime London location, further demonstrates Dalata’s ability to increase its footprint in London, a major global hub for both business and tourism. This latest acquisition will bring the total number of Dalata bedrooms in London to 877 keys, once Maldron Hotel Finsbury Park opens in June 2023 and Maldron Hotel Shoreditch opens in 2024.

Dermot Crowley, CEO of Dalata Hotel Group plc, said: London is one of the world’s great cities. Securing existing hotels or sites to develop new hotels is very challenging as a result. I am delighted that we have managed to secure two new hotels in the city in the space of just four months. It demonstrates our ability to re-invest the funds that we generate from our existing hotels. We look forward to welcoming our new colleagues into the Dalata family.”

 

Shane Casserly, Corporate Development Director, Dalata Hotel Group plc, said: “To have acquired such an attractive existing London hotel, in the current market, that will allow us to further expand the Clayton brand, is a fantastic achievement for the business. London remains a key development market for us and we remain focused on securing future opportunities for the portfolio.”

 

ENDS

 

 

About Dalata

Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014. Dalata is Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group’s portfolio comprises 50 three and four-star hotels with 10,953 rooms and a pipeline of over 1,400 rooms. The Group currently has 29 owned hotels, 18 leased hotels and three management contracts. Dalata successfully operates Ireland’s two largest hotel brands, the Clayton and the Maldron Hotels. For the year ended 31 December 2022, Dalata reported revenue of €558.3 million and a profit after tax of €96.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

 

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:PFU
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
Sequence No.:248026
EQS News ID:1647727
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
21st Apr 20207:00 amRNSSale & Leaseback of Clayton Charlemont Hotel
20th Apr 20201:05 pmRNSStatement re AGM
17th Apr 20203:01 pmRNSHolding(s) in Company
14th Apr 20209:12 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSHolding(s) in Company
1st Apr 20209:09 amRNSTotal Voting Rights
30th Mar 20205:33 pmRNSNotice of AGM
25th Mar 202012:00 pmRNSCovid-19 Update
23rd Mar 202011:00 amRNSHolding(s) in Company
20th Mar 20205:50 pmRNSDirector/PDMR Shareholding
20th Mar 20202:47 pmRNSDirector/PDMR Shareholding
19th Mar 20202:41 pmRNSDirector/PDMR Shareholding
18th Mar 202011:17 amRNSHolding(s) in Company
18th Mar 202010:45 amRNSHolding(s) in Company
18th Mar 202010:25 amRNSHolding(s) in Company
16th Mar 20204:41 pmRNSDirector/PDMR Shareholding
13th Mar 20205:17 pmRNSAnnual Financial Report
12th Mar 202012:21 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSEuronext Dublin Market Notice
10th Mar 20203:20 pmRNSHolding(s) in Company
10th Mar 20203:04 pmRNSHolding(s) in Company
9th Mar 202010:01 amRNSCOVID 19 Update
4th Mar 20209:40 amRNSStatement Block Listing Application
3rd Mar 20209:30 amRNSTotal Voting Rights
28th Feb 20203:10 pmRNSDirector/PDMR Shareholding
27th Feb 20203:52 pmRNSHolding(s) in Company
27th Feb 20209:39 amRNSHolding(s) in Company
25th Feb 20207:00 amRNSFull Year Results 2019
13th Feb 20209:52 amRNSHolding(s) in Company
13th Feb 20207:00 amRNSSigned a New Lease Agreement
5th Feb 20208:07 amRNSTotal Voting Rights
20th Jan 20204:29 pmRNSHolding(s) in Company
7th Jan 20202:59 pmRNSBlock listing Interim Review
7th Jan 20202:35 pmRNSNotice of Results
3rd Jan 202010:02 amRNSTotal Voting Rights
18th Dec 20197:00 amRNSTrading and Development Update
17th Dec 20197:00 amRNSDirector Appointment and Board Committee Changes
16th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:40 pmRNSHolding(s) in Company
4th Dec 20193:30 pmRNSDirector/PDMR Shareholding
3rd Dec 201910:12 amRNSTotal Voting Rights
28th Nov 20198:15 amRNSReplacement Holding(s) in Company
27th Nov 20193:55 pmRNSHolding(s) in Company
21st Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:09 pmRNSAcquisition
14th Nov 20199:07 amRNSDirector Declaration
5th Nov 20195:15 pmRNSHolding(s) in Company - Replacement
1st Nov 20199:45 amRNSTotal Voting Rights
24th Oct 20193:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.